Mashi 2023: Izinhlobo ezimbalwa ze-lymphoma, kanye ne-leukemia ethile kanye ne-myeloma eminingi, manje zingelashwa ngempumelelo ngokwelashwa kwe-CAR-T. Ucwaningo lwakamuva lukhombisile ukusebenza ngempumelelo kokwelashwa kwe-CAR-T kusenesikhathi.
Agasti 2021: I-FDA inikeze i-axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) imvume esheshayo ezigulini ezikhulile ezine-lymphoma ephindaphindekayo noma e-refractory follicular lymphoma (FL) ngemva kwemigqa emibili noma ngaphezulu yokwelashwa kwe-systemic. Ingoma..